Journal article icon

Journal article

iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria

Abstract:
Nitric oxide (NO) has fundamental roles in numerous physiological and pathophysiological processes. In macrophages, NO produced by inducible nitric oxide synthase (iNOS) modulates metabolic changes that are essential to macrophage activation and plasticity, driving the characteristic metabolic switch from oxidative phosphorylation to glycolysis1, 2. Itaconate, derived from the TCA cycle by decarboxylation of cis-aconitate by IRG1 (also referred to as CAD, ACOD1), is one of the most upregulated metabolites during the inflammatory response3. Itaconate regulates macrophage polarization by electrophilically modifying cysteines of key enzymes that control inflammatory states (such as ATF3, Jak1, IFNβ), participate in glycolysis (for example, GAPDH, LDHA) and limit oxidative stress through structural competitive inhibition of succinate dehydrogenase4, 5, 6, 7, 8–9. We recently reported that macrophages that are deficient in iNOS, and subsequent NO generation, produce strikingly higher levels of intracellular itaconate (up to ~15-fold) compared to wild-type cells when stimulated with inflammatory cytokines1, 2, 10. Here we show that iNOS inhibits IRG1 activity and itaconate levels through a conformation-dependent protein–protein interaction rather than through the production of NO. Using a variety of biochemical and computational approaches, we show that a direct interaction between iNOS and IRG1 occurs within mitochondria, in mouse and human cells, and that it depends on binding of the cofactor BH4 to iNOS but does not require its capability to produce NO. Our findings reveal a non-canonical cellular function for iNOS that places it at the centre of a signalling hub, linking redox signalling and metabolism to modulation of the inflammatory response in macrophages.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author
ORCID:
0000-0001-7982-5678
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Role:
Author
ORCID:
0009-0007-6425-1182
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Centre for Human Genetics
Role:
Author
ORCID:
0000-0002-7512-6252


More from this funder
Funder identifier:
10.13039/501100000266
Grant:
EP/W522582/1
More from this funder
Funder identifier:
10.13039/501100000274
Grant:
FS/14/56/31049
More from this funder
Funder identifier:
10.13039/501100005617
Grant:
RE/13/1/30181


Publisher:
Nature Research
Journal:
Nature Metabolism More from this journal
Volume:
8
Issue:
4
Pages:
855-868
Publication date:
2026-04-10
Acceptance date:
2026-02-23
DOI:
EISSN:
2522-5812
ISSN:
2522-5812


Language:
English
Keywords:
Pubs id:
2404868
Local pid:
pubs:2404868
Source identifiers:
3993998
Deposit date:
2026-04-28
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP